Everpure
P
152.66
+5.46
+3.71%
Everpure
US · P
#509 by market cap
Listed 1970
152.66
+5.46
+3.71%
Live - 5344 symbols - heartbeat 75s ago
· 2026-10-08 06:44
Pre-market
150.40
-1.48%
After-hours
153.81
+0.75%
Overnight
151.50
-0.76%
- Market cap
- 50.87B
- P/E (TTM)i
- 209.12
- P/Bi
- 33.01
- EPSi
- 0.55
- Div yieldi
- 0.00%
- 52W posi
- 99%
Reader sentiment
Are you bullish or bearish on P?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 10.26, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.61% YoY
Margins
- Gross margin
- 70.38%
- Operating margin
- 3.13%
- Net margin
- 5.14%
Key ratios & quality
- PEG ratioi
- 5.64
- Altman Z-Scorei
- 10.26
PEG uses trailing P/E against the 3-year net income growth rate (37.07%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.36B | 1.64B | 1.68B | 2.18B | 2.75B | 2.83B | 3.17B | 3.66B |
| Gross profit | 902.30M | 1.13B | 1.15B | 1.47B | 1.90B | 2.02B | 2.21B | 2.58B |
| Selling & admin expenses | 721.62M | 891.18M | 898.49M | 988.98M | 1.12B | 1.20B | 1.31B | 1.50B |
| Research & development | 349.94M | 433.66M | 480.47M | 581.94M | 692.53M | 736.76M | 804.41M | 963.29M |
| Operating profit | -169.26M | -191.28M | -230.03M | -98.40M | 83.51M | 87.16M | 101.16M | 114.82M |
| Pretax profit | -177.27M | -194.67M | -270.16M | -128.50M | 91.81M | 90.59M | 147.83M | 224.28M |
| Tax | 1.09M | 6.32M | 11.92M | 14.76M | 18.74M | 29.28M | 41.10M | 36.10M |
| Net profit | -178.36M | -200.99M | -282.08M | -143.26M | 73.07M | 61.31M | 106.74M | 188.18M |
| Basic EPS | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 1 |
| Diluted EPS | -0.77 | -0.79 | -1.05 | -0.50 | 0.23 | 0.19 | 0.31 | 0.55 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 778.49M | 861.00M | 964.45M | 1.06B | 1.05B | 1.19B |
| Gross profit | 536.15M | 604.34M | 697.38M | 740.09M | 723.33M | 811.39M |
| Selling & admin expenses | 345.58M | 357.44M | 387.10M | 409.73M | 444.30M | 454.48M |
| Research & development | 221.74M | 242.03M | 256.36M | 243.16M | 259.09M | 293.75M |
| Operating profit | -31.17M | 4.87M | 53.92M | 87.20M | 19.94M | 63.16M |
| Pretax profit | 484.00K | 50.57M | 65.71M | 107.52M | 33.87M | 72.16M |
| Tax | 14.48M | 3.45M | 10.90M | 7.27M | 9.79M | -1.99M |
| Net profit | -14.00M | 47.12M | 54.81M | 100.25M | 24.08M | 74.15M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | 0.14 | 0.16 | 0.29 | 0.07 | 0.21 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.70B | 1.89B | 1.91B | 2.19B | 2.47B | 2.50B | 2.57B | 3.06B |
| Cash & ST investments | 1.20B | 1.30B | 1.25B | 1.41B | 1.58B | 1.53B | 1.52B | 1.55B |
| Inventory | 44.69M | 38.52M | 46.73M | 38.94M | 50.15M | 42.66M | 42.81M | 75.94M |
| Total assets | 1.97B | 2.36B | 2.82B | 3.14B | 3.54B | 3.66B | 3.96B | 4.67B |
| Total current liabilities | 509.82M | 614.74M | 760.65M | 952.32M | 1.75B | 1.37B | 1.60B | 1.91B |
| Short-term debt | -- | 27.26M | 32.23M | 36.13M | 613.65M | 48.87M | 143.88M | 44.65M |
| Long-term debt | 449.83M | 477.01M | 755.81M | 786.78M | -- | 100.00M | -- | -- |
| Total liabilities | 1,235,245,000.00 | 1,534,086,000.00 | 2,069,434,000.00 | 2,380,979,000.00 | 2,602,227,000.00 | 2,385,666,000.00 | 2,657,467,000.00 | 3,228,591,000.00 |
| Total equity | 737.78M | 830.12M | 750.01M | 754.34M | 941.23M | 1.27B | 1.31B | 1.45B |
| Retained earnings | -1.08B | -1.28B | -1.57B | -1.71B | -1.54B | -1.48B | -1.37B | -1.18B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.40B | 2.52B | 2.65B | 3.06B | 3.05B | 3.32B |
| Cash & ST investments | 1.58B | 1.54B | 1.53B | 1.55B | 1.50B | 1.01B |
| Inventory | 37.55M | 46.81M | 82.42M | 75.94M | 77.94M | 106.30M |
| Total assets | 3.81B | 4.03B | 4.22B | 4.67B | 4.75B | 5.22B |
| Total current liabilities | 1.49B | 1.53B | 1.61B | 1.91B | 1.89B | 2.20B |
| Short-term debt | 141.56M | 47.08M | 44.16M | 44.65M | 45.37M | 50.27M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 2,566,310,000.00 | 2,707,716,000.00 | 2,815,522,000.00 | 3,228,591,000.00 | 3,307,809,000.00 | 3,679,571,000.00 |
| Total equity | 1.24B | 1.32B | 1.40B | 1.45B | 1.44B | 1.54B |
| Retained earnings | -1.38B | -1.34B | -1.28B | -1.18B | -1.16B | -1.08B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 164.42M | 189.57M | 187.64M | 410.13M | 767.23M | 677.72M | 753.60M | 880.09M |
| Depreciation & amortization | 70.88M | 89.71M | 70.04M | 83.15M | 100.43M | 124.42M | 126.65M | 147.82M |
| Free cash flow | 64.18M | 92.73M | 92.67M | 307.84M | 609.10M | 482.56M | 526.87M | 615.74M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -20.00M | -15.02M | -135.18M | -200.17M | -219.07M | -135.80M | -373.98M | -342.65M |
| Ending cash balance | 463.81M | 377.92M | 347.69M | 476.74M | 591.40M | 712.13M | 737.75M | 864.98M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 283.94M | 212.16M | 115.99M | 268.00M | 180.16M | -136.35M |
| Depreciation & amortization | 33.77M | 35.93M | 37.79M | 40.33M | 40.20M | 41.58M |
| Free cash flow | 211.59M | 150.13M | 52.57M | 201.45M | 111.75M | -237.60M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -119.94M | -42.24M | -53.27M | -127.20M | -84.10M | -68.98M |
| Ending cash balance | 760.14M | 909.69M | 874.11M | 864.98M | 848.66M | 396.44M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -28.87 | -25.64 | -35.70 | -19.05 | 8.62 | 5.55 | 8.29 | 13.68 |
| ROA %i | -11.69 | -9.27 | -10.88 | -4.81 | 2.19 | 1.70 | 2.80 | 4.36 |
| ROIC %i | -16.46 | -15.28 | -17.62 | -7.31 | 3.75 | 1.99 | 3.67 | 8.53 |
| 5-year avg ROE %i | -- | -57.59 | -32.29 | -27.59 | -19.79 | -13.24 | -6.46 | 3.42 |
| EBIT margin %i | -11.45 | -10.26 | -14.18 | -4.21 | 3.51 | 3.46 | 4.91 | 6.22 |
| FCF / sales %i | 4.72 | 5.64 | 5.50 | 14.12 | 22.12 | 17.05 | 16.63 | 16.81 |
| Current ratioi | 3.34 | 3.08 | 2.51 | 2.30 | 1.41 | 1.83 | 1.61 | 1.60 |
| Quick ratioi | 3.09 | 2.86 | 2.25 | 2.05 | 1.25 | 1.61 | 1.38 | 1.30 |
| Debt / assetsi | 22.80 | 25.26 | 32.22 | 29.23 | 21.34 | 7.44 | 7.09 | 4.64 |
| LT debt / equityi | 60.97 | 68.66 | 116.82 | 116.69 | 15.14 | 17.57 | 10.51 | 11.90 |
| Interest coveragei | -7.20 | -6.47 | -7.60 | -2.50 | 20.33 | 13.11 | 19.92 | 67.45 |
| Revenue CAGR (3Y) %i | 45.62 | 30.52 | 18.01 | 17.05 | 18.77 | 18.90 | 13.26 | 9.98 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | 37.07 |
| FCF CAGR (3Y) %i | -- | -- | 129.20 | 68.65 | 87.28 | 73.33 | 19.62 | 0.36 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 9.76 | 10.04 | 9.27 | 13.68 | 16.85 | 17.71 |
| ROA %i | 3.44 | 3.57 | 3.23 | 4.36 | 5.29 | 5.48 |
| ROIC %i | 5.00 | 5.55 | 5.06 | 8.53 | 10.99 | 12.32 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.64 | 5.64 | 5.05 | 6.22 | 6.59 | 6.58 |
| FCF / sales %i | 17.39 | 16.40 | 16.27 | 16.81 | 13.10 | 3.01 |
| Current ratioi | 1.61 | 1.65 | 1.65 | 1.60 | 1.62 | 1.51 |
| Quick ratioi | 1.33 | 1.35 | 1.34 | 1.30 | 1.27 | 0.93 |
| Debt / assetsi | 7.12 | 5.55 | 5.36 | 4.64 | 4.86 | 4.32 |
| LT debt / equityi | 10.43 | 13.36 | 12.97 | 11.90 | 12.87 | 11.36 |
| Interest coveragei | 24.13 | 28.49 | 35.42 | 67.45 | 143.60 | 267.47 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Product revenue is the largest reported line at 57.91% of revenue, across 2 reported segments.
- Subscription services revenue follows at 42.09%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Product revenue57.91%
Subscription services revenue42.09%
Quote time 2026-10-08 06:44:27 · For reference only, not investment advice and not tailored to your situation.